| ASSET | MONTH | % RETURN |
|---|---|---|
Cytokinetics (CYTK) | June 2013 | 62.04% |
RH (RH) | June 2013 | 34.92% |
ACADIA Pharmaceuticals (ACAD) | June 2013 | 28% |
Vicor (VICR) | June 2013 | 26.85% |
GameStop (GME) | June 2013 | 26.67% |
Nexstar Broadcasting (NXST) | June 2013 | 25.61% |
Pilgrims Pride (PPC) | June 2013 | 24.71% |
Home Bancshares, Inc (Conway, AR) (HOMB) | June 2013 | 23.08% |
Vera Therapeutics (VERA) | June 2013 | 22.03% |
Ligand Pharmaceuticals (LGND) | June 2013 | 21.74% |
VNET Group Inc DRC (VNET) | June 2013 | 21.44% |
VSE (VSEC) | June 2013 | 21.36% |
ePlus (PLUS) | June 2013 | 20.48% |
Matador Resources (MTDR) | June 2013 | 20.04% |
Camtek (CAMT) | June 2013 | 20% |
ArcBest (ARCB) | June 2013 | 19.84% |
Quantum Computing (QUBT) | June 2013 | 18.18% |
Option Care Health (OPCH) | June 2013 | 18.11% |
Avadel Pharmaceuticals (AVDL) | June 2013 | 16.91% |
First Bancorp (FBP) | June 2013 | 15.88% |
Thor Industries (THO) | June 2013 | 15.34% |
Tegna (TGNA) | June 2013 | 14.96% |
Qualys (QLYS) | June 2013 | 14.25% |
Glacier Bancorp (GBCI) | June 2013 | 14.21% |
CorVel (CRVL) | June 2013 | 13.82% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
